Status:
UNKNOWN
Clinic Versus Home Spirometry
Lead Sponsor:
University of Nottingham
Collaborating Sponsors:
AstraZeneca
Conditions:
Asthma
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The study aims to assess the differences between spirometry performed with the NuvoAir Air Next spirometer in the clinic setting with both direct and virtual supervision via a video call, and in the h...
Eligibility Criteria
Inclusion
- An ability to provide fully informed consent.
- A diagnosis of asthma or COPD.
- Male or female aged ≥18 and ≤ 80 years of age.
Exclusion
- Symptoms suggestive of COVID-19.
- An exacerbation of asthma or COPD or symptoms of a respiratory infection within the 30 days prior to the first visit.
- Any other clinically significant medical disease or uncontrolled concomitant disease, that is likely, in the opinion of the Investigator(s), to impact on the ability to participate in the study.
- The presence of any contraindications to spirometry.
Key Trial Info
Start Date :
December 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT05219773
Start Date
December 14 2021
End Date
May 1 2022
Last Update
February 2 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Respiratory Research Unit
Nottingham, Nottinghamshire, United Kingdom, NG51PB
2
Bradford Teaching Hospitals NHS Foundation Trust
Bradford, United Kingdom, BD9 6RJ
3
The Rotherham NHS Foundation Trust
Rotherham, United Kingdom, S60 2UD